CTRI/2017/07/009041已完成未知
Efficacy and safety of intralesional MMR vaccine and Formic acid application in the treatment of common warts: a comparative study
Myfanwy Joanne Dsouza0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age above 18 years.
- •Patients satisfying the diagnostic criteria.
- •Common warts restricted only to the hands and feet, upto a maximum of 10 lesions.
- •Patients willing for the intervention with a written informed consent.
排除标准
- •Age more than 72 years.
- •Patients with secondary infection of the warts.
- •Pregnant and lactating women.
- •Immunocompromised individuals.
- •Individuals with chronic and systemic illnesses like Diabetes mellitus, renal diseases
研究者
相似试验
尚未招募
4 期
Comparison Between Intralesional MMR vaccine and Intralesional Vit D in treatment of Plane WartsCTRI/2023/08/055966MAMC
尚未招募
3 期
The effect of MMR vaccine in preventing Covid disease 19IRCT20200802048266N1Ahvaz University of Medical Sciences323
尚未招募
不适用
Safety and efficacy of intramuscular vaccination without aspiration before injection: a randomized clinical trialDrug-Related Side Effects and Adverse Reactions. Signals e Symptons.C25.100C23.888RBR-8nkhhkniversidade Federal de Alagoas - UFA
尚未招募
不适用
Risk analysis in intramuscular vaccine injectioJPRN-UMIN000048777TOKYO WOMEN'S MEDICAL SCHOOL ADACHI MEDICAL CENTER30
已完成
3 期
Intralesional measles, mumps, rubella (MMR) vaccine versus tuberculin purified protein derivative (PPD) in the treatment of palmoplantar and periungual warts: A randomized controlled trialClearance of wartswarts , tuberculin purified protein derivative (PPD), measles, mumps, rubella (MMR) vaccine , intralesionalTCTR20200604014Division of Dermatology, Department of medicine, Faculty of Medicine, Ramathibodi hospital40